Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients (Q36492408)

14 August 2017

1 reference

title

Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients (English)

1 reference

polyomavirus-associated nephropathy

14 August 2017

1 reference

Trofe J

1

1 reference

PubMed ID

16734630

14 August 2017

Hirsch HH

series ordinal

2

1 reference

PubMed ID

16734630

14 August 2017

Ramos E

series ordinal

3

1 reference

14 August 2017

1 June 2006

1 reference

Transplant Infectious Disease

14 August 2017

1 reference

14 August 2017

8

1 reference

14 August 2017

2

1 reference

14 August 2017

76-85

1 reference

Human polyoma virus-associated interstitial nephritis in the allograft kidney

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Clinical course of polyoma virus nephropathy in 67 renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Polyomavirus nephropathy in native kidneys of non-renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Leflunomide for polyomavirus type BK nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Treatment of refractory BK virus-associated nephropathy with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Monitoring the progress of BK virus associated nephropathy in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

BK transplant nephropathy successfully treated with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Polyomavirus nephropathy in pediatric kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Retransplantation in patients with graft loss caused by polyoma virus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Histologic versus molecular diagnosis of BK polyomavirus-associated nephropathy: a shifting paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Statin Use and Bone Mineral Density in Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

Retransplantation after polyomavirus-associated nephropathy: just do it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00166.X

10.1111/J.1399-3062.2006.00166.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16734630